PlainRecalls
FDA Drug Low Class III Terminated

Zoledronic Acid Injection, 5 mg/100 mL (0.05 mg/mL) One 100ml Single-Dose Bottle, Rx Only. NOVAPLUS Mfd By: Gland Pharma Limited D.P. Pally - 500 043 India: Mfd. For: Dr. Reddy's Laboratories Limited Bachupally - 500 090 India. N+ and NOVAPLUS are registered trademarks of Vizient, Inc. NDC 43598-331-11

Reported: October 3, 2018 Initiated: September 12, 2018 #D-0104-2019

Product Description

Zoledronic Acid Injection, 5 mg/100 mL (0.05 mg/mL) One 100ml Single-Dose Bottle, Rx Only. NOVAPLUS Mfd By: Gland Pharma Limited D.P. Pally - 500 043 India: Mfd. For: Dr. Reddy's Laboratories Limited Bachupally - 500 090 India. N+ and NOVAPLUS are registered trademarks of Vizient, Inc. NDC 43598-331-11

Reason for Recall

Failed Impurities/Degradation Specifications: OOS for unknown impurities.

Details

Units Affected
10,530 vials
Distribution
Product was distributed to retailers, distributors, physician officers and medical facilities throughout the United States.
Location
Princeton, NJ

Frequently Asked Questions

What product was recalled?
Zoledronic Acid Injection, 5 mg/100 mL (0.05 mg/mL) One 100ml Single-Dose Bottle, Rx Only. NOVAPLUS Mfd By: Gland Pharma Limited D.P. Pally - 500 043 India: Mfd. For: Dr. Reddy's Laboratories Limited Bachupally - 500 090 India. N+ and NOVAPLUS are registered trademarks of Vizient, Inc. NDC 43598-331-11. Recalled by Dr. Reddy's Laboratories, Inc.. Units affected: 10,530 vials.
Why was this product recalled?
Failed Impurities/Degradation Specifications: OOS for unknown impurities.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 3, 2018. Severity: Low. Recall number: D-0104-2019.